AdaptHealth Corp.
NASDAQ:AHCO
10.09 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 805.858 | 805.975 | 792.497 | 858.234 | 804.031 | 793.286 | 744.626 | 780.283 | 557.654 | 727.614 | 706.203 | 702.106 | 653.293 | 617.017 | 482.119 | 348.429 | 284.405 | 232.116 | 191.439 | 149.541 | 136.451 | 124.154 | 119.498 | 108.652 | 102.156 | 67.235 | 67.235 |
Cost of Revenue
| 693.129 | 690.368 | 687.058 | 709.823 | 693.488 | 673.397 | 655.396 | 699.322 | 646.714 | 610.011 | 597.122 | 591.62 | 529.887 | 490.72 | 396.698 | 290.38 | 240.72 | 197.517 | 166.54 | 123.212 | 111.111 | 98.048 | 97.717 | 90.027 | 84.287 | 55.445 | 55.445 |
Gross Profit
| 112.729 | 115.607 | 105.439 | 148.411 | 110.543 | 119.889 | 89.23 | 80.961 | -89.06 | 117.603 | 109.081 | 110.486 | 123.406 | 126.297 | 85.421 | 58.049 | 43.685 | 34.599 | 24.899 | 26.329 | 25.34 | 26.106 | 21.781 | 18.626 | 17.869 | 11.79 | 11.79 |
Gross Profit Ratio
| 0.14 | 0.143 | 0.133 | 0.173 | 0.137 | 0.151 | 0.12 | 0.104 | -0.16 | 0.162 | 0.154 | 0.157 | 0.189 | 0.205 | 0.177 | 0.167 | 0.154 | 0.149 | 0.13 | 0.176 | 0.186 | 0.21 | 0.182 | 0.171 | 0.175 | 0.175 | 0.175 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 49.242 | 57.012 | 48.378 | 47.294 | 45.198 | 50.078 | 47.521 | 37.452 | 40.681 | 42.548 | 41.444 | 34.921 | 33.006 | 42.946 | 56.632 | 31.601 | 26.306 | 17.092 | 14.347 | 24.985 | 1.195 | 1.799 | 0.291 | 0.432 | 0.391 | 0.163 | 0.051 |
Selling & Marketing Expenses
| 0 | 9.2 | 0 | -1.139 | 0 | 0 | 0 | 19.2 | 0 | 0 | 0 | 18.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.1 | 0 | 0 | 0 | 1.788 | 0 | 0 | 0 |
SG&A
| 49.242 | 57.012 | 48.378 | 46.155 | 45.198 | 50.078 | 47.521 | 37.452 | 40.681 | 42.548 | 41.444 | 34.921 | 33.006 | 42.946 | 56.632 | 31.601 | 26.306 | 17.092 | 14.347 | 24.985 | 1.195 | 1.799 | 0.291 | 0.432 | 0.391 | 0.163 | 0.051 |
Other Expenses
| 0 | 1.76 | -5.105 | -22.992 | -3.317 | -2.082 | 15.532 | 16.777 | -182.69 | 15.877 | 16.085 | -1.134 | 0.452 | -1.669 | 0.519 | -56.867 | 4.12 | 1.037 | 1.242 | 2.919 | 0.05 | 0.05 | 0.05 | 0.05 | 0.054 | 0.072 | 0.022 |
Operating Expenses
| 49.242 | 57.012 | 48.378 | 46.155 | 59.713 | 65.627 | 63.053 | 54.229 | -142.009 | 58.425 | 57.529 | 41.407 | 47.696 | 60.89 | 70.012 | 22.299 | 30.426 | 18.129 | 15.588 | 25.615 | 1.245 | 1.849 | 0.341 | 0.482 | 0.445 | 0.234 | 0.073 |
Operating Income
| 63.487 | 58.595 | 57.061 | 102.256 | -461.036 | 54.262 | 26.177 | 26.732 | 52.949 | 59.178 | 51.552 | 69.079 | 75.71 | 65.407 | 15.409 | 35.75 | 13.259 | 16.47 | 9.311 | 0.714 | -1.245 | -1.849 | -0.341 | -0.482 | -0.445 | -0.234 | -0.073 |
Operating Income Ratio
| 0.079 | 0.073 | 0.072 | 0.119 | -0.573 | 0.068 | 0.035 | 0.034 | 0.095 | 0.081 | 0.073 | 0.098 | 0.116 | 0.106 | 0.032 | 0.103 | 0.047 | 0.071 | 0.049 | 0.005 | -0.009 | -0.015 | -0.003 | -0.004 | -0.004 | -0.003 | -0.001 |
Total Other Income Expenses Net
| -31.459 | -30.816 | -51.56 | -373.942 | -506.023 | -1.27 | -11.216 | -23.57 | -30.142 | -35.078 | -3.719 | -9.973 | 18.955 | 50.128 | 1.439 | -56.867 | -5.316 | -7.482 | -7.938 | -45.74 | 1.367 | 1.482 | 1.464 | 1.423 | 1.205 | 1.157 | 0.365 |
Income Before Tax
| 32.028 | 27.779 | 5.501 | -271.686 | -487.499 | 20.44 | 14.961 | 3.162 | 22.807 | 24.1 | 47.833 | 33.495 | 70.413 | 92.388 | -5.337 | -34.721 | -4.463 | 8.988 | 1.373 | -6.939 | 0.122 | -0.367 | 1.123 | 0.941 | 0.76 | 0.922 | 0.292 |
Income Before Tax Ratio
| 0.04 | 0.034 | 0.007 | -0.317 | -0.606 | 0.026 | 0.02 | 0.004 | 0.041 | 0.033 | 0.068 | 0.048 | 0.108 | 0.15 | -0.011 | -0.1 | -0.016 | 0.039 | 0.007 | -0.046 | 0.001 | -0.003 | 0.009 | 0.009 | 0.007 | 0.014 | 0.004 |
Income Tax Expense
| 8.073 | 7.248 | 6.61 | -18.111 | -34.578 | 5.399 | -1.714 | 4.733 | 5.58 | 8.853 | 5.603 | 10.024 | 12.147 | 12.33 | -1.695 | -7.219 | -0.636 | 1.819 | 1.107 | -4.288 | 0.277 | 0.301 | 0.297 | 0.284 | 0.242 | 0.232 | 0.072 |
Net Income
| 22.859 | 19.435 | -2.134 | -254.503 | -454.076 | 13.977 | 15.707 | -1.571 | 13.402 | 12.846 | 38.213 | 21.135 | 48.088 | 72.199 | -3.966 | -31.043 | -2.489 | 4.351 | -0.158 | -3.426 | -0.154 | -0.667 | 0.826 | 0.658 | 0.518 | 0.69 | 0.22 |
Net Income Ratio
| 0.028 | 0.024 | -0.003 | -0.297 | -0.565 | 0.018 | 0.021 | -0.002 | 0.024 | 0.018 | 0.054 | 0.03 | 0.074 | 0.117 | -0.008 | -0.089 | -0.009 | 0.019 | -0.001 | -0.023 | -0.001 | -0.005 | 0.007 | 0.006 | 0.005 | 0.01 | 0.003 |
EPS
| 0.17 | 0.13 | -0.016 | -1.91 | -3.37 | 0.1 | 0.11 | -0.012 | 0.1 | 0.094 | 0.28 | 0.16 | 0.4 | 0.56 | -0.036 | -0.47 | -0.043 | 0.1 | -0.004 | -0.11 | -0.007 | -0.032 | 0.026 | 0.021 | 0.017 | 0.022 | 0.007 |
EPS Diluted
| 0.17 | 0.13 | -0.016 | -1.91 | -3.36 | 0.09 | -0.06 | -0.012 | 0.097 | 0.094 | 0.28 | 0.15 | 0.2 | 0.12 | -0.034 | -0.47 | -0.043 | 0.08 | -0.004 | -0.1 | -0.007 | -0.031 | 0.026 | 0.021 | 0.017 | 0.022 | 0.007 |
EBITDA
| 73.624 | 159.335 | 162.922 | 202.301 | 144.823 | 151.476 | 118.815 | 50.435 | 145.023 | 137.39 | 122.922 | 145.171 | 145.99 | 81.682 | 29.308 | -16.142 | 17.379 | 34.844 | 10.552 | 1.344 | -1.245 | -1.849 | -0.341 | -0.482 | -0.445 | -0.234 | -0.073 |
EBITDA Ratio
| 0.091 | 0.198 | 0.206 | 0.236 | 0.18 | 0.191 | 0.16 | 0.065 | 0.26 | 0.189 | 0.174 | 0.207 | 0.223 | 0.132 | 0.061 | -0.046 | 0.061 | 0.15 | 0.055 | 0.009 | -0.009 | -0.015 | -0.003 | -0.004 | -0.004 | -0.003 | -0.001 |